National Institute of Allergy and Infectious Diseases (NIAID)
CAUSE-05/RHINO is an observational study designed to learn how babies' nasal cells grow and change during the first months of life. The study will enroll pregnant mothers in their third trimester and their infants upon delivery for a target population of 60 mother-baby pairs. Researchers will conduct up to 6 study visits and collect serial nasal samples through 4 months of age.
This is an observational, multicenter study designed to assess developmental changes in in vivo and in cultured neonatal nasal epithelial cells. The study will enroll pregnant females in their third trimester of pregnancy as well as their infants upon delivery. Approximately 60 mother-infant pairs will be observed from birth to age 4 months to describe early-life developmental patterns of nasal cell gene expression, including genes related to type-II (T2) inflammation, immune response, and epithelial barrier function.
Inclusion Criteria: 1. Able to understand and provide informed consent 2. Age 18 years or older 3. Currently pregnant, with: 1. Gestational age ≥ 28 weeks as confirmed by participant self-report 2. Intent to deliver at a participating clinical site labor and delivery (L\&D) center 4. Agrees to enroll infant into the study at birth 5. In the case of multiple gestation, agrees to enroll only one infant who will be randomly selected 6. Have a primary place of residence in one of the pre-selected recruitment census tracts as outlined in the Protocol CAUSE-05 (RHINO) Manual of Procedures (M…
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.